The rise of bioengineered materials in surgical and medical devices...

The rise of bioengineered materials in surgical and medical devices

نشر بتاريخ 2023-10-31 10:04:20

2كيلو بايت

Market Overview:

The medical engineered materials market involves products crafted from novel compounds designed for their biocompatibility and functional suitability in medical applications. Key product offerings include bioabsorbable materials, biocompatible polymers, metallic alloys, and composite materials used across surgical sutures, implants, prosthetics, and various medical devices.

SWOT Analysis:

· Strength: High demands from medical devices industry, Availability of advanced material engineering technologies.

· Weakness: High R&D costs associated with developing new materials, stringent regulations.

· Opportunity: Emerging economies improving healthcare infrastructure, wider adoption of 3D printing.

· Threats: Supply chain disruptions, trade barriers affecting material imports.

Key Takeaways:

The Global Medical Engineered Materials Market Size is expected to witness high growth, exhibiting CAGR of 14.3% over the forecast period, due to increasing investments in developing advanced healthcare infrastructure especially in emerging economies.

North America dominated the medical engineered materials market in 2023, owing to presence of majority key players and higher adoption of advanced materials in surgical procedures & medical devices. Asia Pacific is expected to exhibit the highest growth rate during the forecast period with growing medical tourism and rising healthcare expenditure in the region.

Key players operating in the medical engineered materials market include Evonik Industries AG, Covestro AG, BASF SE, Solvay, SABIC, Trelleborg AB, DSM, Celanese Corporation, DuPont de Nemours Inc., B. Braun Melsungen AG, Huntsman Corporation, Eastman Chemical Company, Nitto Denko Corporation, Sekisui Chemical Co., Ltd., Teknor Apex Company, WL Gore & Associates Inc., Zimmer Biomet Holdings Inc., Smith & Nephew PLC, Johnson & Johnson, Medtronic PLC. These players are focusing on developing innovative bio-compatible materials and establishing partnerships with medical devices manufacturers.